Affinity and Avidity in Antibody-Based Tumor Targeting
- 1 April 2009
- journal article
- research article
- Published by Mary Ann Liebert Inc in Cancer Biotherapy & Radiopharmaceuticals
- Vol. 24 (2) , 155-161
- https://doi.org/10.1089/cbr.2009.0627
Abstract
Many factors contribute to successful tumor targeting by antibodies. Besides properties of the tumor tissue and general antibody pharmacology, a relationship exists between an antibody and its antigen that can shape penetration, catabolism, specificity, and efficacy. The affinity and avidity of the binding interactions play critical roles in these dynamics. In this work, we review the principles that guide models predicting tumor penetration and cellular internalization while providing a critical overview of studies aimed at experimentally determining the specific role of affinity and avidity in these processes. One should gain the perspective that binding affinity can, in part, dictate the localization of antibodies in tumors, leading to high concentrations in the perivascular space or low concentrations diffused throughout the tumor. These patterns can be simply due to the diminution of available dose by binding antigen and are complicated by internalization and degradation stemming from slow rates of dissociation. As opposed to the trend of simply increasing affinity to increase efficacy, novel strategies that increase avidity and broaden specificity have made significant progress in tumor targeting.Keywords
This publication has 49 references indexed in Scilit:
- Targeting ErbB2 and ErbB3 with a bispecific single-chain Fv enhances targeting selectivity and induces a therapeutic effect in vitroBritish Journal of Cancer, 2008
- Effect of antigen turnover rate and expression level on antibody penetration into tumor spheroidsMolecular Cancer Therapeutics, 2008
- Quantitative Spatiotemporal Analysis of Antibody Fragment Diffusion and Endocytic Consumption in Tumor SpheroidsCancer Research, 2008
- Antibody Engineering Principles and ApplicationsThe Cancer Journal, 2008
- Antibody tumor penetration: Transport opposed by systemic and antigen-mediated clearanceAdvanced Drug Delivery Reviews, 2008
- Kinetics of anti-carcinoembryonic antigen antibody internalization: effects of affinity, bivalency, and stabilityCancer Immunology, Immunotherapy, 2008
- Engineered antibody fragments and the rise of single domainsNature Biotechnology, 2005
- Biological Effects of Anti-ErbB2 Single Chain Antibodies Selected for Internalizing FunctionBiochemical and Biophysical Research Communications, 2001
- Isolation of Picomolar Affinity Anti-c-erbB-2 Single-chain Fv by Molecular Evolution of the Complementarity Determining Regions in the Center of the Antibody Binding SiteJournal of Molecular Biology, 1996
- Isolation of High-affinity Monomeric Human Anti-c-erbB-2 Single chain Fv Using Affinity-driven SelectionJournal of Molecular Biology, 1996